Jacobson Pharma Corporation 2633.HK · HKD

Its shares trade on HKEX under the ticker 2633.HK. It has been listed since 21 September 2016. In the fiscal year to 31 March 2026, it reported revenue of HK$1.57bn and net income of HK$301.6m. At that date it held total assets of HK$3.56bn and shareholders' equity of HK$2.32bn.

Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors. The company employs 1,789 full-time employees The company went IPO on 2016-09-21. The firm operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Kwong Yip SumExecutive Chairman of the Board, Chief Executive Officer, since 2016HK$5.2m
• Mr. Chun Kau YuChief Financial Officer, Company Secretary, since 2021
• Ms. Yue Wai PunExecutive Director, since 2016HK$1.6m
• Mr. Chun Leung YimExecutive Director, since 2016HK$3.2m
• Prof. Chi Kei WongNon-Executive DirectorHK$220,000
• Dr. Kwing Tong LamNon-Executive Independent DirectorHK$220,000
• Mr. Ting Lung LukNon-Executive Independent Director
• Mr. Chun Man YoungNon-Executive Independent DirectorHK$220,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.